The polymerase chain reaction
Haemophilia A is an inheritable haemorrhagic disorder caused by a heterogeneous array of genetic lesions that result in a deficiency of the blood clotting protein factor VIII.' Because the gene for factor VIII is located on the distal portion of the long arm of the X chromosome, phenotypically normal females within an affected kindred may be carriers of the disorder. Detection of haemophilia carriers is typically performed by gene tracking of affected X chromosomes using restriction fragment length polymorphism (RFLP) analysis.2 Two frequently occurring RFLPs have been described within the factor VIII gene.34 The radioisotopes. Rapid analyses by the PCR have been reported for prenatal diagnosis and carrier testing in a variety of disorders including sickle cell anaemia, phenylketonuria, and cystic fibrosis in addition to haemophilia. Furthermore, fetal sexing using the PCR has been reported using amiocytes, chorionic villi, and single cells taken from developing blastocysts.7'-2 PCR has also been applied to the study of residual leukaemia.'3 As far as we know this is the first report of rapid gene analysis in haemophilia achieved by the PCR on DNA obtained from buccal cells, hair follicles, and urine samples. We found that all the crude material amplified well using thermostable DNA polymerase and cycling was completed within a few hours. Analysis using the method described here can be performed within one day: conventional procedures normally take up to 10 days. Our findings that the amplified XbaI region will only partially cleave with XbaI restriction endonuclease supports the work of others who prospose that a good proportion of the product is not factor VIII gene in origin and therefore does not possess a restriction site for this enzyme.6 This is probably due to a lack of specificity of the primers and consequently reduces the diagnostic capacity of this particular reaction. The use of further XbaI primers should improve this.
The use of non-invasive techniques is a principal attraction of the procedure with regard to ease of collection of samples, particularly relating to younger family members. Diagnosis can be made quickly and cheaply with minimum inconvenience to patients under investigation. PCR procedures are technically undemanding, obviate the need for radioisotope handling, and lend themselves easily to automation. Despite this the risk offalse results due to contaminating material or by the lack of fidelity of the reaction is a potential problem. Furthermore, the stability of stored crude DNA samples is as yet unknown.
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